Prediction of atmospheric corrosion from meteorological parameters: Case of the atmospheric basin of the Costa Rican Western Central Valley

La evaluación de la corrosión atmosférica se basa actualmente en el estudio de las cuencas atmosféricas (AB, por sus siglas en inglés). La modelización de la corrosión atmosférica implica en muchos casos la medición de varios parámetros meteorológicos y de contaminación atmosférica, concretamente la temperatura, la humedad relativa, el cloruro y el dióxido de azufre, lo que hace más complejo el proceso de estimación. Sin embargo, para el Valle Central Occidental (WCV, por sus siglas en inglés) de Costa Rica, un AB de baja contaminación, es posible desarrollar modelos simplificados de corrosión atmosférica, basados en un pequeño número de parámetros atmosféricos. En este trabajo se analizaron las variables meteorológicas de la región de estudio en cuanto a su dependencia de la altitud y su aplicabilidad en el desarrollo de un modelo simplificado para predecir la tasa de corrosión (Vcorr). El resultado del modelo de predicción se comparó con el modelo estándar de la norma ISO 9223:2012, mostrando una mayor habilidad y dando resultados fiables para un amplio intervalo de altitudes.The assessment of atmospheric corrosion is currently based on the study of atmospheric basins (AB). Modeling atmospheric corrosion in many cases involves the measurement of several meteorological and atmospheric pollution parameters, specifically temperature, relative humidity, chloride, and sulfur dioxide, making the estimation process more complex. However, for the Western Central Valley (WCV) in Costa Rica, a low-pollution AB, it is possible to develop simplified atmospheric corrosion models based on a small number of atmospheric parameters. In this paper, the meteorological variables of the study region were analyzed in terms of their dependency on altitude and their applicability in the development of a simplified model to predict the corrosion rate (Vcorr). The output of the predictive model was compared with the standard model of ISO 9223:2012, showing a higher skill and giving reliable results for a wide interval of altitudes.Universidad de Costa Rica/[805-B8-650]/UCR/Costa RicaUCR::Vicerrectoría de Investigación::Unidades de Investigación::Ciencias Básicas::Centro de Investigaciones Geofísicas (CIGEFI)UCR::Vicerrectoría de Docencia::Ciencias Sociales::Facultad de Ciencias Sociales::Escuela de Geografí

Secondary phytohaemagglutinin (PHA) swelling response is a good indicator of T-cell-mediated immunity in free-living birds

El phytohaemagglutinin (PHA) se prueba para medir la inmunidad adquirida y es uno de los métodos más utilizados; actualmente, está siendo debatido a raíz de los nuevos conocimientos sobre la compleja fisiología del proceso. Como respuesta secundaria reiterada a los mayores desafíos vinculados a los aumentos de los niveles de linfocitos T circulantes sería indicativo de una respuesta inmune mediada por células, se realizó por primera vez un experimento bajo condiciones naturales con repetidas PHA desafíos en libre-viviendo los pájaros adultos y polluelos para arrojar luz sobre este tema. Hemos encontrado significativamente más fuerte respuesta a PHA inyección secundaria independiente del sexo o la edad, mientras que el control de la condición corporal, la segunda respuesta es en promedio 90% más grande que el primero. Igualmente, los recuentos de linfocitos fueron significativamente superiores en el segundo reto de PHA, mientras que no se encontraron diferencias significativas entre las aves no tratadas. Las correlaciones positivas significativas entre la PHA respuesta y ambos recuentos de linfocitos y los niveles de proteínas plasmáticas (principalmente albúmina, globulina (precursor) fueron recuperados, mientras que no hubo diferencias significativas en los niveles de proteínas plasmáticas recuperados entre los retos. Nuestros resultados son consistentes con las aves cautivas, apoyando la validez del PHA de la hinchazón de la piel como prueba precisa de haber adquirido células T como la inmunidad en aves.The validity of using the phytohaemagglutinin (PHA) test to measure acquired immunity, one of the most widely used methods, is currently being debated due to new knowledge on the complex physiology of the process. As a greater secondary response to repeated challenges linked to increases of circulating lymphocyte levels would be indicative of a T-cell-mediated immune response, we performed for the first time an experiment under natural conditions with repeated PHA challenges in free-living adult birds and chicks to shed light on this topic. We found significantly stronger secondary response to PHA injection independent of sex or age, while controlling for body condition, the second response being on average 90% larger than the first. Likewise, lymphocyte counts were significantly higher in the second PHA challenge, whereas no significant differences were found among untreated birds. Significant positive correlations between the PHA response and both lymphocyte counts and plasma protein levels (mainly albumin, globulin (precursor) were recovered, whereas no significant differences were recovered in plasma protein levels between challenges. Our results are consistent with those from captive birds, supporting the validity of the PHA skin-swelling test as an accurate gauge of acquired T-cell-mediated immunity in birds.Trabajo patrocinado por: Fondo Mejicano para Conservación de la Naturaleza. Proyecto PIE 2012 A-P-C-IGSI-12-12 Gobierno de Extremadura. CONACYT (I010/176/2012) y becas PO10014 y RE12002 Gobierno de Extremadura. Dirección General de Vida Silvestre. SGPA/ DGVS/08559/11peerReviewe

Epidemiological characterization of ischemic heart disease at different altitudes: a nationwide population-based analysis from 2011 to 2021 in Ecuador

Background Cardiovascular diseases, including ischemic heart disease, are the leading cause of prema- ture death and disability worldwide. While traditional risk factors such as smoking, obesity, and diabetes have been thoroughly investigated, non-traditional risk factors like high-alti- tude exposure remain underexplored. This study aims to examine the incidence and mortal- ity rates of ischemic heart disease over the past decade in Ecuador, a country with a diverse altitude profile spanning from 0 to 4,300 meters. Methods We conducted a geographic distribution analysis of ischemic heart disease in Ecuador, uti- lizing hospital discharge and mortality data from the National Institute of Census and Statis- tics for the years 2011–2021. Altitude exposure was categorized according to two distinct classifications: the traditional division into low ( 2,500 m) altitudes, as well as the classification proposed by the International Society of Mountain Medicine, which delineates low (2500 m. Men had more pronounced rates across altitudes, exhibiting 138.7% and 150.0% higher incidence at low and high altitudes respectively, and mortality rates increased by 48.3% at low altitudes and 23.2% at high altitudes relative to women. Conclusion Ecuador bears a significant burden of ischemic heart disease (IHD), with men being more affected than women in terms of incidence. However, women have a higher percentage of mortality post-hospital admission. Regarding elevation, our analysis, using two different alti- tude cutoff points, reveals higher mortality rates in low-altitude regions compared to high- altitude areas, suggesting a potential protective effect of high elevation on IHD risk. Never- theless, a definitive dose-response relationship between high altitude and reduced IHD risk could not be conclusively established

Mesotelioma maligno epitelioide

This is a male patient of 57 years old with personal medical history of smoking, and to suffer alcoholism, high blood pressure, dilated cardiomyopathy and chronic kidney disease stage V. He had several hospital admissions by pleural effusion in one of them was appreciated serohematic aspect of the liquid with negative cytological study of neoplastic cells. He evolved torpidly and joined to effusion dysphagia, fever, hemoptysis and intense epigastric pain. Pathological findings showed a malignant mesothelioma type epithelioid with invasion to the lung, the diaphragm and the pericardium that led him to death with a pulmonary embolism saddle. The morphological characteristics of this tumor are very similar to adenocarcinoma, so special cytochemical techniques are required for diagnosis.Se trata de un paciente masculino de 57 años, con antecedentes patológicos personales de ser fumador y de padecer alcoholismo, hipertensión arterial, miocardiopatía dilatada y enfermedad renal crónica estadio V. Tuvo varios ingresos por derrame pleural, en uno de ellos se apreció aspecto serohemático del líquido con estudio citológico negativo de células neoplásicas. Evolucionó tórpidamente y se sumaron al derrame la disfagia, la fiebre, la hemoptisis y una epigastralgia intensa. Los hallazgos anatomopatológicos mostraron un mesotelioma maligno tipo epitelioide con invasión al pulmón, al diafragma y al pericardio que lo llevó a fallecer con un tromboembolismo pulmonar en silla de montar. Las características morfológicas de este tumor son muy similares al adenocarcinoma, por lo que se requieren técnicas citoquímicas especiales para su diagnóstico

Serologic evidence of west nile virus infection in birds, Tamaulipas State, México

Following the introduction of West Nile virus (WNV) into North America in 1999, surveillance for WNV in migratory and resident birds was established in Tamaulipas State, northern México in December 2001. Overall, 796 birds representing 70 species and 10 orders were captured and assayed for antibodies to WNV. Nine birds had flavivirus-specific antibodies by epitope-blocking enzyme-linked immunosorbent assay; four were confirmed to have antibody to WNV by plaque reduction neutralization test. The WNV-infected birds were a house wren, mourning dove, verdin and Bewick's wren. The house wren is a migratory species; the other WNV-infected birds are presumably residents. The WNV-infected birds were all captured in March 2003. These data provide the first indirect evidence of WNV transmission among birds in northern México

Immune response and reactogenicity after immunization with two-doses of an experimental COVID-19 vaccine (CVnCOV) followed by a third-fourth shot with a standard mRNA vaccine (BNT162b2): RescueVacs multicenter cohort study

Background: There is no evidence to date on immunogenic response among individuals who participated in clinical trials of COVID-19 experimental vaccines redirected to standard national vaccination regimens. Methods: This multicentre, prospective controlled cohort study included subjects who received a COVID-19 experimental vaccine (CVnCoV)(test group, TG) - and unvaccinated subjects (control group, CG), selected among individuals to be vaccinated according to the Spanish vaccination program. All study subjects received BNT162b2 as a standard national vaccination schedule, except 8 (from CG) who received mRNA-1273 and were excluded from immunogenicity analyses. Anti-RBD antibodies level and neutralising titres (NT50) against G614, Beta, Mu, Delta and Omicron variants were analysed. Reactogenicity was also assessed. Findings: 130 participants (TG:92; CG:38) completed standard vaccination. In TG, median (IQR) of anti-RBD antibodies after first BNT162b2 dose were 10740·0 BAU/mL (4466·0-12500) compared to 29·8 BAU/mL (14·5-47·8) in CG (p <0·0001). Median NT50 (IQR) of G614 was 2674·0 (1865·0-3997·0) in TG and 63·0 (16·0-123·1) in CG (p <0·0001). After second BNT162b2 dose, anti-RBD levels increased to ≥12500 BAU/mL (11625·0-12500) in TG compared to 1859·0 BAU/mL (915·4-3820·0) in CG (p <0·0001). NT50 was 2626·5 (1756·0-5472·0) and 850·4 (525·1-1608·0), respectively (p <0·0001). Variant-specific (Beta, Mu, Omicron) response was also assessed. Most frequent adverse reactions were headache, myalgia, and local pain. No severe AEs were reported. Interpretation: Heterologous BNT162b2 as third and fourth doses in previously suboptimal immunized individuals elicit stronger immune response than that obtained with two doses of BNT162b2. This apparent benefit was also observed in variant-specific response. No safety concerns arose.This work is partially funded by Institute of Health Carlos III (Instituto de Salud Carlos III − ISCIII −), (grants PI19CIII/00004 −JA- and PI21CIII/00025 −MPO, JG-), and COVID-19 FUND (grants COV20/00679 −MPO- and COV20/00072 −JA-) and CIBERINFEC, co-financed by the European Regional Development Fund (FEDER) “A way to make Europe”. Instituto de Salud Carlos III is a Spanish public body assigned to the Ministry of Science and Innovation that manages and promotes public clinical research related to public health. The authors thank Esther Prieto, MD (cited with consent) for editorial assistance and writing support (funded by the Research Foundation of HCSC).S

Cirrosis hepática y ascitis quilosa, una enfermedad corriente con presentación inusual

This is a female patient of 61 years with personal pathological history of hypertension, diabetes mellitus type 2 and liver cirrhosis. She was admitted at hospital with a diagnosis of chylous ascites and the probability of lymphoma versus peritoneal tuberculosis and it was performed multiple imaging studies that reported no tumor process. She evolved unfavorably until she presented diffuse peritonitis superimposed, hepatorenal syndrome and taking of the general state with electrolyte imbalance and acid-base. Pathological findings showed liver cirrhosis with diffuse peritonitis fibrinopurulent superadded to chylous ascites; she died with failure of multiple organ. Cirrhosis occupies 0.5% of the causes of chylous ascites.Se trata de una paciente femenina de 61 años, con antecedentes patológicos personales de hipertensión arterial, diabetes mellitus tipo 2 y cirrosis hepática. Ingresó con diagnóstico de ascitis quilosa y la probabilidad de linfoma versus tuberculosis peritoneal y se le realizaron múltiples estudios imagenológicos que no informaron proceso tumoral. Evolucionó desfavorablemente hasta presentar peritonitis difusa fibrinopurulenta sobreañadida, síndrome hepatorrenal y toma del estado general con desequilibrio hidroelectrolítico y ácido básico. Los hallazgos anatomopatológicos mostraron una cirrosis hepática con peritonitis fibrinopurulenta difusa sobreañadida a ascitis quilosa; falleció con daño y fallo de múltiples órganos. La cirrosis ocupa el 0.5% de las causas de ascitis quilosa

Additional file 1 of Immunological and senescence biomarker profiles in patients after spontaneous clearance of hepatitis C virus: gender implications for long-term health risk

Additional file 1. Biochemical characteristics of 56 individuals stratified by HCV infection status and sex.Ministerio de Ciencia e Innovación; Consorcio Centro de Investigación Biomédica en Red; Instituto de Salud Carlos III; Fundación Universidad Alfonso X el SabioPeer reviewe

A Proof-Of-Principle Study of Epigenetic Therapy Added to Neoadjuvant Doxorubicin Cyclophosphamide for Locally Advanced Breast Cancer

BACKGROUND: Aberrant DNA methylation and histone deacetylation participate in cancer development and progression; hence, their reversal by inhibitors of DNA methylation and histone deacetylases (HDACs) is at present undergoing clinical testing in cancer therapy. As epigenetic alterations are common to breast cancer, in this proof-of-concept study demethylating hydralazine, plus the HDAC inhibitor magnesium valproate, were added to neoadjuvant doxorubicin and cyclophosphamide in locally advanced breast cancer to assess their safety and biological efficacy. METHODOLOGY: This was a single-arm interventional trial on breast cancer patients (ClinicalTrials.gov Identifier: NCT00395655). After signing informed consent, patients were typed for acetylator phenotype and then treated with hydralazine at 182 mg for rapid-, or 83 mg for slow-acetylators, and magnesium valproate at 30 mg/kg, starting from day –7 until chemotherapy ended, the latter consisting of four cycles of doxorubicin 60 mg/m(2) and cyclophosphamide 600 mg/m(2) every 21 days. Core-needle biopsies were taken from primary breast tumors at diagnosis and at day 8 of treatment with hydralazine and valproate. MAIN FINDINGS: 16 patients were included and received treatment as planned. All were evaluated for clinical response and toxicity and 15 for pathological response. Treatment was well-tolerated. The most common toxicity was drowsiness grades 1–2. Five (31%) patients had clinical CR and eight (50%) PR for an ORR of 81%. No patient progressed. One of 15 operated patients (6.6%) had pathological CR and 70% had residual disease <3 cm. There was a statistically significant decrease in global 5(m)C content and HDAC activity. Hydralazine and magnesium valproate up- and down-regulated at least 3-fold, 1,091 and 89 genes, respectively. CONCLUSIONS: Hydralazine and magnesium valproate produce DNA demethylation, HDAC inhibition, and gene reactivation in primary tumors. Doxorubicin and cyclophosphamide treatment is safe, well-tolerated, and appears to increase the efficacy of chemotherapy. A randomized phase III study is ongoing to support the efficacy of so-called epigenetic or transcriptional cancer therapy